Bullish case
$225 to $245
More likely if adjusted EPS compounds near low double digits, IQOS and ZYN keep taking share, smoke-free revenue mix expands, debt leverage falls, and the market keeps assigning a premium consumer staples multiple.
Philip Morris International Inc. research snapshot
PM AI Stock Analysis
PM AI stock analysis currently reads Philip Morris International Inc. as a high-quality global nicotine business whose investment case depends on smoke-free growth, pricing power, and disciplined deleveraging after the Swedish Match acquisition. At the July 8, 2026 data cutoff, the latest verified close used here was $187.79 on July 7, 2026, with an implied market capitalization of about $292.68 billion. The AI stock forecast uses scenarios, not a certain price prediction, and this page is informational research rather than investment advice.
Current price
$187.79
Market cap
$292.68 billion
AI score
74 / 100
Rating
High quality compounder, valuation sensitive
Trend status
Strong uptrend above major moving averages
Data cutoff (updated weekly)
July 8, 2026
Informational use only. This page is not investment advice.
Research quality check
- information Richness
- A-level information richness. PMI has long public filings, fresh Q1 2026 earnings materials, active analyst coverage, third-party financial data, and current technical snapshots.
- bias Check
- The main AI bias risk is over-weighting the popular smoke-free transformation narrative. This page separates verified revenue, EPS, debt, and share-count facts from uncertain judgments about regulation, nicotine pouch growth, IQOS adoption, and valuation multiples.
- ai Confidence
- High data confidence
- investment Certainty
- Medium. Historical data and market-cap math are well supported, but investment certainty is capped by tobacco regulation, litigation, currency, U.S. ZYN supply normalization, debt, and the price already discounting a strong execution path.
Quick verdict table
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | PMI sells cigarettes, heated tobacco, nicotine pouches, e-vapor, and adjacent wellness products to adult consumers, with smoke-free products reaching 41.5% of 2025 net revenues and 43% of Q1 2026 net revenues. | High |
| Moat | Moat comes from Marlboro and IQOS brand equity, global distribution, scale, regulation that raises barriers, device and consumable ecosystems, and growing switching costs in heated tobacco. | Medium-high |
| Management | Jacek Olczak has led PMI since 2021 and owns a meaningful executive stake, while the key scorecard is smoke-free execution, U.S. ZYN recovery, capital returns, and leverage control. | Medium-high |
| Financial trend | 2025 net revenues grew 7.3% to $40.648 billion, operating income grew 11.1% to $14.892 billion, and Q1 2026 net revenues rose 9.1% to $10.1 billion. | High |
| Valuation | At $187.79, verified TTM PE is about 26.45x and P/FCF is about 27.45x, so valuation depends on continued smoke-free growth and sustained pricing power. | Medium-high |
| Technical trend | Daily technical data showed a strong buy summary, RSI near 63.6, and price above the 20-day, 50-day, 100-day, and 200-day moving averages at the cutoff. | Medium |
| Risk level | Risk is medium because the business is profitable and diversified, but regulation, litigation, currency, debt, nicotine pouch competition, and a rich multiple can damage returns. | High |
| AI confidence | High for reported financials, Q1 2026 operating facts, share count, and market-cap math. Lower for forward multiples and regulatory outcomes. | High data confidence |
| Investment certainty | Medium certainty because the business quality is strong, while the current price leaves less room for execution errors than a classic value setup. | Medium |
PM AI stock forecast
PM AI Stock Forecast Scenarios
The PM AI stock forecast uses three-year scenario ranges around the $187.79 cutoff close. The financial-rigor model produced a bullish value near $236.30, a base value near $191.40, and a bearish value near $109.70 using EPS growth and terminal PE assumptions. These are scenario outputs, not promises.
Base case
$182 to $200
More likely if Q1 2026 momentum continues, combustibles remain price resilient, smoke-free products grow but the valuation multiple stays near current levels.
Bearish case
$102 to $118
More likely if regulation, tax, litigation, currency, or ZYN supply and competition pressures slow EPS growth and investors compress the multiple toward a lower tobacco peer range.
PM AI technical analysis
PM AI Technical Analysis
PM AI technical analysis uses the July 7, 2026 close of $187.79 and technical snapshots available at the July 8, 2026 data cutoff. The setup was positive, with Investing.com showing daily strong buy signals and the stock above major moving averages, while the share price was close to its recent 52-week high.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $187.79 | Latest verified close used for this page, dated July 7, 2026. |
| Near support | $185.48 to $185.82 | Classic and Fibonacci pivot support and pivot area reported by Investing.com on July 7, 2026. |
| Moving average support | $181.88 to $179.68 | Investing.com reported the 50-day SMA at $181.88 and the 200-day SMA at $179.68 on July 7, 2026. |
| Deeper support | $160.03 to $163.82 | ChartMill identified this as a multi-time-frame support zone in its public PM technical snapshot. |
| Near resistance | $187.24 to $193.05 | The lower level is an Investing.com classic R3 pivot. MarketWatch cited a 52-week high of $193.05 reached on May 19, 2026. |
| 50-day moving average | $181.88 | Price was above the 50-day average, supporting the short-term uptrend at the cutoff. |
| 200-day moving average | $179.68 | Price was above the 200-day average, supporting the longer trend at the cutoff. |
| Momentum | RSI 63.599 | Investing.com reported RSI(14) at 63.599, positive but not above the classic 70 overbought line. |
| Volume | 3.7 million vs 5.0 million average | MarketWatch reported July 7 trading volume below the 50-day average, so breakout confirmation still matters. |
| Volatility | ATR(14) 1.7286 | Investing.com reported lower volatility by ATR, but regulatory or earnings headlines can still create gap risk. |
| Invalidation | Close below $181.88, then $179.68 | A close below the 50-day average weakens the trend setup. Losing the 200-day average would challenge the longer technical case. |
PM AI trading strategy
PM AI Trading Strategy Framework
The PM AI trading strategy is a rules-based research framework. It is not personalized advice. Traders should pair it with live price data, earnings dates, FDA and international regulatory headlines, currency moves, dividend timing, and position sizing.
Trend-following setup
Watch for PM to hold above the $181.88 to $179.68 moving-average support zone and then break the $193.05 high with volume above the recent average.
A failed breakout or daily close below the 50-day moving average invalidates the short-term trend setup.
Mean-reversion setup
If PM pulls back toward the 50-day or 200-day average without a negative filing, earnings miss, FDA action, or ZYN supply issue, compare valuation, dividend yield, and smoke-free momentum before considering reversion exposure.
Do not average down if the pullback is tied to worsening smoke-free growth, debt concerns, or a durable loss of pricing power.
Fundamental monitor
Track smoke-free revenue mix, IQOS shipment volume, ZYN U.S. shipment recovery, organic net revenue growth, adjusted EPS guidance, total debt, cash conversion, dividend coverage, and regulatory filings.
Reduce confidence when upside depends mainly on multiple expansion instead of verified EPS growth and free cash flow.
Investment research summary
Four-master Research Compression
Business essence
PMI monetizes adult nicotine demand globally by selling combustibles and increasingly smoke-free products, with IQOS, ZYN, and VEEV shifting the profit pool away from cigarettes.
Moat
The moat is strongest in brand, route-to-market scale, regulatory know-how, product ecosystem, and manufacturing capability. It widens if smoke-free consumers stay inside PMI platforms.
Munger risk inversion
The failure path is harsher regulation, litigation, excise tax pressure, currency drag, ZYN supply or share loss, IQOS adoption slowdown, debt strain, and valuation compression from a premium multiple.
Management
Management has executed a large portfolio transition and Swedish Match integration, but the next proof points are U.S. ZYN recovery, debt reduction, smoke-free profitability, and disciplined capital allocation.
Industry trend
Combustible tobacco is structurally pressured, while smoke-free nicotine is the long-term growth vector. PMI is positioned in a shift from burning tobacco to lower-risk delivery formats, though the category remains regulated and contested.
Valuation and margin of safety
At $187.79, PM is not priced as a distressed tobacco stock. The margin of safety depends on high confidence in smoke-free growth, stable combustibles pricing, cash conversion, and a premium multiple holding.
Source-backed data
PM Data Table
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| Latest close | $187.79 on July 7, 2026 | StockAnalysis PM financials page | July 8, 2026 |
| Market capitalization | $292.68 billion, verified by $187.79 x 1,558,530,268 shares | PMI 2026 proxy statement and CompaniesMarketCap | July 8, 2026 |
| Shares outstanding | 1,558,530,268 shares as of March 13, 2026 record date | PMI 2026 proxy statement | July 8, 2026 |
| 2025 net revenues | $40.648 billion, cross-checked against StockAnalysis and Macrotrends | PMI 2025 annual report | July 8, 2026 |
| 2025 operating income | $14.892 billion, up 11.1% from 2024 | PMI 2025 annual report | July 8, 2026 |
| 2025 net earnings attributable to PMI | $11.348 billion, with third-party net income difference below 1% | PMI 2025 annual report | July 8, 2026 |
| 2025 smoke-free revenue mix | $16.854 billion, or 41.5% of 2025 net revenues | PMI 2025 annual report | July 8, 2026 |
| Q1 2026 net revenues | $10.1 billion, up 9.1% reported and 2.7% organically year over year | PMI Q1 2026 results | July 8, 2026 |
| Q1 2026 smoke-free revenue mix | 43% of total net revenues, with smoke-free products available in 108 markets | PMI investor relations overview | July 8, 2026 |
| Cash and total debt | $5.46 billion cash and $51.98 billion debt on a TTM basis; 2025 cash cross-check matched at $4.872 billion | StockAnalysis PM statistics and balance sheet | July 8, 2026 |
| Valuation metrics | TTM PE 26.45x, P/FCF 27.45x, FCF yield 3.64%, dividend yield 3.13% | financial_rigor.py verification using StockAnalysis TTM data | July 8, 2026 |
| Technical snapshot | Daily strong buy, RSI(14) 63.599, 50-day SMA $181.88, 200-day SMA $179.68 | Investing.com PM technical analysis | July 8, 2026 |
Frequently Asked Questions
Read the MO AI stock analysisView the PEP AI stock forecastExplore the STZ AI technical analysisGenerate an AI trading strategy
This PM AI stock analysis is an informational tool only and is not investment advice, financial advice, or a recommendation to buy or sell any security. Forecast scenarios are based on available data at the stated cutoff date and can be wrong. Always verify live data and consult a qualified adviser for decisions tied to your personal situation.